Posts for Stewarding Entity: Board of Directors
-
American College of Medical Genetics position statement on gene patents and accessibility of gene testing
-
ACMG Statement on Direct-to-Consumer Genetic Testing
-
Points to consider in the clinical application of genomic sequencing
-
Clarifications to ACMG’s recent statement on The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG)
-
Phenylalanine hydroxylase deficiency diagnosis and management: A 2023 evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)
-
Updated recommendations for CFTR carrier screening: A position statement of the American College of Medical Genetics and Genomics (ACMG)
-
Noninvasive prenatal screening for fetal chromosome abnormalities in a general-risk population: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)
-
Direct-to-consumer prenatal testing for multigenic or polygenic disorders: a position statement of the American College of Medical Genetics and Genomics (ACMG)
-
Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)
-
DNA-based screening and personal health: a points to consider statement for individuals and healthcare providers from the American College of Medical Genetics and Genomics (ACMG)